StreetAlpha.app
Home › Stocks › CDNA

CareDx, Inc. (CDNA)

Healthcare
$70.00
▼ −2.67%
LAST CLOSE · NOV 20

CareDx provides transplant testing, donor matching products, software and pharmacy services for transplant centers and patients. It last closed at $70.00 on Nov 20, down 2.67% on the day. The next earnings report for CDNA is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, CDNA reported EPS of $0.35 on revenue of $139.4M, with revenue up 39.3% from a year ago. Over its last 8 reports the stock moved an average of 15.1% the session after earnings. Over the last 12 months CDNA insiders bought $0 of stock on the open market and sold $20.1M, according to SEC Form 4 filings.

AI Auto Pilots
Is CDNA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CDNA.

Key Stats

Last 12 months
Results
Revenue
$497.4M
+38.9% vs a year ago
Net income
$128.6M
+82.6% vs a year ago
EPS (diluted)
$2.37
+85.2% vs a year ago
Operating margin
23.4%
$116.5M operating income
Valuation
Market cap
$3.7B
52.5M shares
P/E
29.5
Price over 12 month EPS
Price to sales
7.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$250.5M
At Sep 30
Shareholder equity
$467.5M
Buybacks
$24.4M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $296.4M$296.4MFY2021FY2022: $321.8M$321.8MFY2022FY2023: $280.3M$280.3MFY2023FY2024: $333.8M$333.8MFY2024FY2025: $379.8M$379.8MFY2025

From CDNA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
$0.35
Quarter ended Sep 2026
Year ago EPS
$0.03
+1066.7% on a GAAP basis
Revenue
$139.4M
+39.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.60Dec '24Mar 2025: -$0.19Mar '25Jun 2025: -$0.16Jun '25Sep 2025: $0.03Sep '25Dec 2025: -$0.08Dec '25Mar 2026: $0.05Mar '26Jun 2026: $2.07Jun '26Sep 2026: $0.35Sep '26Latest $0.35
Revenue by quarter
Dec 2024: $86.6MDec '24Mar 2025: $84.7MMar '25Jun 2025: $86.7MJun '25Sep 2025: $100.1MSep '25Dec 2025: $108.4MDec '25Mar 2026: $117.7MMar '26Jun 2026: $131.9MJun '26Sep 2026: $139.4MSep '26Latest $139.4M
How CDNA moved after its last 8 reports
Average move the session after a report ±15.1%
Oct 29, 2026After the close+22.2%
Jul 30, 2026After the close+14.7%
Apr 16, 2026Time not announced+27.6%
Feb 24, 2026After the close−4.1%
Jan 12, 2026Time not announced+20.1%
Nov 4, 2025After the close+13.8%
Aug 6, 2025After the close−7.9%
Apr 30, 2025After the close−10.7%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CDNAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CDNA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CDNA

Technical Analysis

CDNA · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock sits between its 20 and 50 day averages. It is 46% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 44). The nearest support is the 50 day average at $68.60, and the nearest resistance the Pivot at $70.73.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 7.0%/day
Key levels
$90.8752 week high+29.8%
$77.7220 day average+11.0%
$72.51Swing high (Oct 6)+3.6%
$72.21Pivot R1+3.2%
$70.73Pivot+1.0%
$70.00Last close
$68.6050 day average−2.0%
$68.53Pivot S1−2.1%
$61.19Swing low (Oct 8)−12.6%
$55.51100 day average−20.7%
$38.04200 day average−45.7%
$15.5652 week low−77.8%
Indicators
RSI (14)43.93Middle of its rangeNeutral
MACD1.30Below its signal lineBearish
Stochastic6.1Near the bottom of its rangeOversold
ADX (14)32.5Trending down
Williams %R-96.4Oversold below −80, overbought above −20Oversold
CCI (20)-94.2Oversold below −100, overbought above 100Neutral
Rate of change−10.9%Change over 10 sessionsBearish
ATR (14)$4.87Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for CDNA

What happened before

See how CDNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CDNA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CDNA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CDNAHow many large options trades hit CDNA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

CDNA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲193 buying vs 110 selling
  • ▼Held by funds -2.3 pts
  • ▲Funds holding +79
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding308229+34.5%
In funds' top 1054+25.0%
Held by funds99.3%101.6%−2.3 pts
New / increased102 / 9152 / 76+50.8%
Reduced / sold out87 / 2368 / 13+35.8%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CDNA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CDNA Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$20.1M23 sales · 9 insiders
82% of the selling was under pre-arranged trading plans.
2025-12 sold $140K2026-01 sold $626K2026-02 sold $91K2026-04 sold $217K2026-05 sold $270K2026-06 sold $2.5M2026-07 sold $5.5M2026-08 sold $3.9M2026-11 sold $6.8MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Richard Bryan RiggsbeeDirectorSale plan5,285$74.77$395K
Nov 12Michael GoldbergDirectorSale plan13,800$79.15$1.1M
Nov 12Keith KennedyCFO & COOSale plan2,097$79.29$166K
Nov 10Jeffrey Adam NovackSecretary and General CounselSale plan4,096$81.13$332K
Nov 5Keith KennedyCFO & COOSale plan61,961$77.82$4.8M
Aug 5George BickerstaffDirectorSale20,000$46.28$926K
Every insider buy and sale for CDNA over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CDNA insider trades →

From SEC Form 4 filings by CDNA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDNA is in one of them and how their past CDNA trades turned out.

CDNA in the AI portfolios
Loading…

CDNA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CDNA in an article yet. Here's the latest on the wider market.

CDNA in the news

CDNA Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 17
Who traded CDNA · since 2019
Latest 5 filings of 14
$1K – $15KTraded Mar 6, 2023Filed Apr 17, 2023
Tom MalinowskiSell (partial)
$1K – $15KTraded Jan 11, 2021Filed Aug 26, 2021
Tom MalinowskiSell (partial)
$1K – $15KTraded Jan 8, 2021Filed Aug 26, 2021
Tom MalinowskiSell (partial)
$15K – $50KTraded Jan 6, 2021Filed Aug 26, 2021
$1K – $15KTraded Dec 29, 2020Filed Aug 26, 2021
PersonTypeAmountTradedFiledDelay
Dan GoldmanD · NYSell$1K – $15KMar 6, 2023Apr 17, 202342 d
Tom MalinowskiD · NJSell (partial)$1K – $15KJan 11, 2021Aug 26, 2021227 d
Tom MalinowskiD · NJSell (partial)$1K – $15KJan 8, 2021Aug 26, 2021230 d
Tom MalinowskiD · NJSell (partial)$15K – $50KJan 6, 2021Aug 26, 2021232 d
Tom MalinowskiD · NJBuy$1K – $15KDec 29, 2020Aug 26, 2021240 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About CareDx

CareDx is a company that offers testing and software for transplant patients and the clinicians who treat them. Its tests check heart, kidney and lung transplant recipients for signs of organ rejection after surgery. The company also sells products that help match donors and recipients before a transplant, software that helps transplant centers manage patient lists and workflow, and specialized pharmacy services for transplant patients. Its main customers are transplant centers, and it is based in Brisbane, California.

Headquarters
Brisbane, CA
Founded
2000